Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
WINDLAS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Low but stable operating margin
Low dividend yield
Neutral
Moderate and stable ROE
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
WINDLAS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
WINDLAS Bulk, Block & Insider Trades
WINDLAS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufactu... Read More
Key personnel
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Windlas Biotech Ltd.?
The current share price of Windlas Biotech Ltd. is ₹ 751.45 as of 09 Jan 2026.
What is the PE ratio of Windlas Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Windlas Biotech Ltd. is 23.33 as of the latest financial data.
What is the ROE and ROCE of Windlas Biotech Ltd.?
Windlas Biotech Ltd. has a Return on Equity (ROE) of 13.39% and a Return on Capital Employed (ROCE) of 13.63% as per the latest financial reports.
What is the market cap of Windlas Biotech Ltd.?
The market capitalization of Windlas Biotech Ltd. stands at ₹ 1,570.53 Cr.
What is the dividend yield of Windlas Biotech Ltd.?
The dividend yield of Windlas Biotech Ltd. is 0.77% based on the current market price.
What is the RSI of Windlas Biotech Ltd.?
The Relative Strength Index (RSI) of Windlas Biotech Ltd. is 38.73.
What is the FII and DII holding in Windlas Biotech Ltd.?
Foreign Institutional Investors (FII) hold 1.11% and Domestic Institutional Investors (DII) hold 6.39% of Windlas Biotech Ltd. shares.
What sector does Windlas Biotech Ltd. belong to?
Windlas Biotech Ltd. operates in the Healthcare sector.
What is the beta of Windlas Biotech Ltd. stock?
The beta of Windlas Biotech Ltd. stock is 1.33, indicating its volatility relative to the broader market.
